Assessing Causality of the Association Between Exercise and Neurocognitive Gains

Sponsor
Nanyang Technological University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05511259
Collaborator
(none)
80
1
2
18.8
4.3

Study Details

Study Description

Brief Summary

Brief Summary: The aim of this project is to examine:
  1. The effects of a community based square stepping exercise programme on cognitive and physical functions in older adults.

  2. The effects of a community based square stepping exercise programme on neuroplasticity in older adults.

  3. The effects of a community based square stepping exercise programme on structural and functional brain changes in older adults.

  4. The relationship between exercise-induced changes in neuroplasticity, structural and functional brain activations, and cognitive and physical gains in older adults.

Condition or Disease Intervention/Treatment Phase
  • Other: exercise
N/A

Detailed Description

It is well known regular exercise produces both physical and cognitive benefits. Emerging evidence suggests that physical movements or exercise that have concurrent cognitive demands may have more profound effects on cognitive and brain health outcomes. One training program that incorporates these components is the square stepping exercise (SSE). First demonstrated in Japan, this community-based paradigm has already shown to reduce falls risk and presents as a convenient exercise modality for older adults, that can be conducted in a group setting or even the home. The current project aims to examine the efficacy of this SSE community programme in a Singapore context on cognitive and physical health in older adults. This study also aims to quantify the neural correlates underpinning any observed improvements in cognitive and physical function. Specifically, this project will measure indices of neuroplasticity via structural and functional magnetic resonance imaging, transcranial magnetic stimulation, and electroencephalography.

Sample size estimation: n=80 for behavioural primary outcome measures and n=40 subset of larger sample for neuroimaging and neuroplasticity secondary outcome measures [anticipated].

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Intervention group: 3-month community based exercise program (square stepping exercise)Intervention group: 3-month community based exercise program (square stepping exercise)
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
Assessing Causality of the Association Between Exercise and Neurocognitive Gains
Actual Study Start Date :
May 10, 2022
Anticipated Primary Completion Date :
Dec 2, 2023
Anticipated Study Completion Date :
Dec 2, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

Square stepping exercise

Other: exercise
Square stepping exercise

No Intervention: Control

Passive control group

Outcome Measures

Primary Outcome Measures

  1. Go-No-Go task change [Baseline (week 0), mid-intervention (week 7 after session 12), post-intervention (week 13 after session 24)]

    Error rate: Number of "Go" responses on "No-Go" trials.

  2. Stroop task colour words and colour blocks [Baseline (week 0), mid-intervention (week 7 after session 12), post-intervention (week 13 after session 24)]

    Average response time (reaction time) for the correct colour word incongruent trials.

  3. N-Back task change [Baseline (week 0), mid-intervention (week 7 after session 12), post-intervention (week 13 after session 24)]

    Number of correct responses (hits)

  4. Trail Making Test ((TMT) change [Baseline (week 0), mid-intervention (week 7 after session 12), post-intervention (week 13 after session 24)]

    B:A: Divide the time taken for TMT B by TMT A

  5. Digit Span task change [Baseline (week 0), mid-intervention (week 7 after session 12), post-intervention (week 13 after session 24)]

    Maximum accurate span length for Digit Span Forward Maximum accurate span length for Digit Span Reverse

  6. Modified Card Sorting task change [Baseline (week 0), mid-intervention (week 7 after session 12), post-intervention (week 13 after session 24)]

    Total number of perseverative errors

  7. Static balance (single leg) change [Baseline (week 0), post-intervention (week 13 after session 24)]

    Duration required to perform single leg stance on left and right legs

  8. Temporal gait parameters change [Baseline (week 0), post-intervention (week 13 after session 24)]

    11-meter gait test to examine gait speed

  9. Motor learning change [Baseline (week 0), post-intervention (week 13 after session 24)]

    Probabilistic Serial Reaction Time Task: learning index, computed using reaction time

Secondary Outcome Measures

  1. Change in cortical thickness [Baseline (week 0), post-intervention (week 13 after session 24)]

    T1 and T2 weighted images

  2. Change in grey matter volume [Baseline (week 0), post-intervention (week 13 after session 24)]

    T1 and T2 weighted images

  3. Change in structural topography [Baseline (week 0), post-intervention (week 13 after session 24)]

    T1 and T2 weighted images

  4. Change in white matter integrity [Baseline (week 0), post-intervention (week 13 after session 24)]

    Diffusion Tensor Imaging

  5. Change in white matter connectivity [Baseline (week 0), post-intervention (week 13 after session 24)]

    Diffusion Tensor Imaging

  6. Change in functional connectivity [Baseline (week 0), post-intervention (week 13 after session 24)]

    Resting state functional magnetic resonance imaging

  7. Brain plasticity changes [Baseline (week 0), post-intervention (week 13 after session 24)]

    Changes in transcranial magnetic stimulation (TMS) induced motor evoked potential amplitudes in response to theta-burst stimulation protocol

  8. Brain plasticity changes [Baseline (week 0), post-intervention (week 13 after session 24)]

    Changes in transcranial magnetic stimulation (TMS)-evoked potentials recorded from electroencephalography (EEG)

  9. Brain plasticity changes [Baseline (week 0), post-intervention (week 13 after session 24)]

    Changes in power spectral density and coherence recorded from electroencephalography (EEG)

Other Outcome Measures

  1. Subjective vitality scale change [Baseline (week 0), post-intervention (week 13 after session 24)]

    5-item vitality score (7-point scale, higher score greater wellbeing outcome)

  2. Heart rate variability change [Baseline (week 0), post-intervention (week 13 after session 24)]

    Measured through deep breathing protocol with electrocardiography (ECG)

  3. Falls risk change [Baseline (week 0), post-intervention (week 13 after session 24)]

    Falls efficiency scale, 16-item and 4-point scale. Lower score equates to more fear of falling and less confident during daily activities.

  4. Social engagement and cohesion [Baseline (week 0), post-intervention (week 13 after session 24)]

    Physical Activity Group Environment Questionnaire: 21 items on 9-point scale. Higher scores = more social connection. The community social participation scale will be used as a covariate when analyzing this scale.

  5. Change in mood (related to movement) [Baseline (week 0), post-intervention (week 13 after session 24)]

    Anxiety and depression subscale of Movement Specific Reinvestment Scale: 10-item, 6-point for anxiety and depression around movement. Higher scores = more symptoms of anxiety and depression.

Eligibility Criteria

Criteria

Ages Eligible for Study:
55 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Older adults aged 55-80

  • Sedentary, defined as exercise less than 3 times per week for 30 minutes

Exclusion Criteria:
  • Square stepping exercise:

  • Medical conditions preventing them from movement and/or exercise

  • Psychiatric conditions

  • Cognitive impairment of dementia

  • Upper and/or lower limb injuries in the past 6 months

  • History of falls in the past 6 months

  • Current smokers

  • Neuroimaging (all the above in addition to the following)

  • Patients who have conductive, ferromagnetic, or magnet-sensitive metals implanted in head (e.g., aneurysm clip, stent).

  • Implanted medical device: e.g., cardiac implants, cochlear implant, aneurysm clips, cardiac pacemaker etc.

  • Non-removable metal braces or retainer (dental fillings ok).

  • Permanent tattoos on head.

  • Deep brain stimulators.

  • Previous brain surgery or injury.

  • Patient with epilepsy or any other seizure history, or immediate family history of epilepsy.

  • Clinical EEG that was abnormal or where seizure activity had not been ruled out.

  • Patients with history of head injury with loss of consciousness are to be investigated about the history if/before being recruited.

  • Diagnosis or possibility of neurological disorder (including stroke).

  • Psychiatric condition.

  • Major or unstable medical condition/surgery.

  • Current or suspected pregnancy or lactation.

  • Illicit drug use in the last 7 days.

  • Alcohol use in the last 12 hours or more than 3 standard drinks in last 24 hours.

  • Recent insomnia or severe sleep deprivation.

  • Participation in another study involving brain stimulation (e.g., TMS, TDCS) in the past 7 days.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Nanyang Technological University Singapore Singapore

Sponsors and Collaborators

  • Nanyang Technological University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
SH Annabel Chen, PhD, Professor of Psychology, School of Social Sciences, Nanyang Technological University
ClinicalTrials.gov Identifier:
NCT05511259
Other Study ID Numbers:
  • MOE2019-T2-1-019
First Posted:
Aug 22, 2022
Last Update Posted:
Aug 22, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by SH Annabel Chen, PhD, Professor of Psychology, School of Social Sciences, Nanyang Technological University

Study Results

No Results Posted as of Aug 22, 2022